1. Hazard JB, Hawk WA, Crile G. Medullary (solid) carcinoma of the thyroid; a clinicopathologic entity. J Clin Endocrinol Metab. 1959;19(1):152–61.
2. Abe K, Adachi I, Miyakawa S, Tanaka M, Yamaguchi K, Tanaka N, et al. Production of calcitonin, adrenocorticotropic hormone, and beta-melanocyte-stimulating hormone in tumors derived from amine precursor uptake and decarboxylation cells. Cancer Res. 1977;37(11):4190–4.
3. Ishikawa N, Hamada S. Association of medullary carcinoma of the thyroid with carcinoembryonic antigen. Br J Cancer. 1976;34(2):111–5.
4. Cancer of the Thyroid Invasive: Trends in SEER Incidence and U.S. Mortality Using the Joinpoint Regression Program, 1975–2011(SEER) Stat version 8.1.2 Rate Session. Access the SEER 18 database at
www.seer.cancer.gov
.
5. Pasini B, Hofstra RM, Yin L, Bocciardi R, Santamaria G, Grootscholten PM, et al. The physical map of the human RET proto-oncogene. Oncogene. 1995;11(9):1737–43.